Denali Therapeutics Inc.

NASDAQ: DNLI · Real-Time Price · USD
14.71
0.25 (1.73%)
At close: Aug 15, 2025, 3:59 PM
15.73
6.97%
After-hours: Aug 15, 2025, 06:45 PM EDT

Denali Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
174.96M 127.11M 218.04M 293.48M
Short-Term Investments
657.37M 907.4M 1.12B 571.93M
Long-Term Investments
359.37M n/a 1.5M 425.45M
Other Long-Term Assets
24.74M 18.14M 11.9M 11.87M
Receivables
2.17M 3.42M 9.28M 1.23M
Inventory
n/a n/a -5M n/a
Other Current Assets
30.61M n/a n/a n/a
Total Current Assets
864.44M 1.06B 1.37B 897.23M
Property-Plant & Equipment
125.63M 71.64M 74.52M 69.61M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
509.74M 89.78M 87.92M 506.93M
Total Assets
1.37B 1.15B 1.46B 1.4B
Account Payables
11.14M 9.48M 2.79M 4.78M
Deferred Revenue
n/a n/a 290.05M 320.3M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
66.34M 21.59M 46.67M 28.7M
Total Current Liabilities
102.21M 77.98M 363.92M 378.25M
Long-Term Debt
42.29M n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 379K 379K
Total Long-Term Liabilities
42.29M 44.98M 53.89M 63.63M
Total Liabilities
144.5M 122.96M 417.81M 441.87M
Total Debt
48.71M 52.24M 60.35M 58.55M
Common Stock
1.77M 1.71M 1.69M 1.55M
Retained Earnings
-1.54B -1.12B -970.99M -645M
Comprehensive Income
2.02M 643K -6.89M -2.5M
Shareholders Equity
1.23B 1.03B 1.04B 962.29M
Total Investments
1.02B 907.4M 1.12B 997.38M